Diwakar Davar

This study is testing whether a fecal transplant from a healthy donor, combined with the immunotherapy drug pembrolizumab, can help people with a certain type of advanced lung cancer (PD-L1 positive non-small cell lung cancer) that has not responded to previous treatments. The tr…

This study tests a drug called tebentafusp in people with a specific type of advanced eye cancer (uveal melanoma) that has spread to other parts of the body. The drug is designed to help the immune system attack cancer cells. Researchers will also use a blood test to measure tumo…

This study looks at whether people with certain cancers prefer getting their immune therapy as a shot under the skin (subcutaneous) or through a needle in a vein (intravenous). About 880 adults who are already eligible for standard treatments like nivolumab or pembrolizumab will …